| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.098 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |